Permanent prostate brachytherapy monotherapy with I-125 for low- and intermediate-risk prostate cancer: Outcomes in 974 patients
To report outcomes of patients undergoing low-dose-rate (LDR) brachytherapy and investigate factors associated with biochemical failure and survival.
Source: Brachytherapy - Category: Cancer & Oncology Authors: David M. Routman, Ryan K. Funk, Bradley J. Stish, Lance A. Mynderse, Torrence M. Wilson, Robert McLaren, W. Scott Harmsen, Kristin Mara, Christopher L. Deufel, Keith M. Furutani, Michael G. Haddock, Thomas M. Pisansky, C. Richard Choo, Brian J. Davis Source Type: research